Annual Secretarial Compliance Certificate for the year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI LODR Regulation 24A. A Practising Company Secretary reviewed the company's adherence to SEBI regulations, circulars, and Secretarial Standards. The company was found to be largely compliant, with just one minor deviation: a delay in submitting AGM voting results to BSE under Reg 44(3), for which BSE levied a fine of ₹10,000 plus GST, which has since been paid. All other compliance areas — including insider trading, related party transactions, website disclosures, director disqualification status, and corporate governance filings — were marked compliant. No action was initiated by SEBI or stock exchanges against the company, its promoters, or directors during the year. All observations flagged in the previous year's report (FY 2022-23) have been rectified.
This is a routine annual compliance filing with no material governance red flags. The only penalty was a minor ₹10,000 fine for a procedural delay in uploading voting results, which is immaterial and already paid. Shareholders should note no SEBI actions against the company or its promoters during the year.